Mind + Muscle

technical minds + legal muscle

Bracket
Sterne Kessler Goldstein Fox
Adam LaRock

Mind + Muscle

Adam LaRock

Associate

 
  • Adam LaRock
  • p 202.772.8794
  • f 202.371.2540
  • alarock@skgf.com

  • v-card

Mr. LaRock is an associate in the Litigation Group. Mr. LaRock concentrates his practice on complex patent litigation, with a special emphasis on pharmaceutical patent litigation under the Hatch-Waxman Act. Mr. LaRock also has experience litigating cases in a wide variety of technologies, including pharmaceuticals, electromechanical apparatuses, diagnostic gene testing, and near field communication devices. He is experienced in all phases of litigation, including injunctions, discovery, and claim construction. In addition, Mr. LaRock has served as trial counsel in multiple proceedings and has handled appeals before the Federal Circuit.

Mr. LaRock graduated from Franklin Pierce Law Center, University of New Hampshire School of Law.  Mr. LaRock served for two years as an Articles Editor for IDEA: The Intellectual Property Law Review.  During to law school, Mr. LaRock also interned as a law clerk for Hon. Carol Ann Conboy, and the New Hampshire Attorney General’s Office.  Prior to joining Sterne Kessler, Mr. LaRock practiced as a patent litigator in the New York area, with particular emphasis on Hatch-Waxman cases.  

  • Represented brand pharmaceutical company and university in multiple Hatch-Waxman cases concerning a nucleoside analog reverse transcriptase inhibitor used to treat HIV infection.
  • Represented generic pharmaceutical company in Hatch-Waxman case concerning antibacterial drug.
  • Represented biotechnology company in district court litigation concerning diagnostic gene testing patents.
  • Represented company in district court litigation concerning stay-voltage detection apparatus patents, and also in appeal from inter partes review proceeding.
  • Represented generic pharmaceutical company in Hatch-Waxman case concerning antipsychotic drug.
  • Represented generic pharmaceutical company in Hatch-Waxman case concerning an enzyme inhibitor used to treat COPD.
  • Represented brand pharmaceutical company in Hatch-Waxman case concerning allergy drug.
  • Represented electronics company in appeal from inter partes review proceeding concerning near field communication devices.
  • Representative Matters

      • Represented brand pharmaceutical company and university in multiple Hatch-Waxman cases concerning a nucleoside analog reverse transcriptase inhibitor used to treat HIV infection.
      • Represented generic pharmaceutical company in Hatch-Waxman case concerning antibacterial drug.
      • Represented biotechnology company in district court litigation concerning diagnostic gene testing patents.
      • Represented company in district court litigation concerning stay-voltage detection apparatus patents, and also in appeal from inter partes review proceeding.
      • Represented generic pharmaceutical company in Hatch-Waxman case concerning antipsychotic drug.
      • Represented generic pharmaceutical company in Hatch-Waxman case concerning an enzyme inhibitor used to treat COPD.
      • Represented brand pharmaceutical company in Hatch-Waxman case concerning allergy drug.
      • Represented electronics company in appeal from inter partes review proceeding concerning near field communication devices.
  • Admissions
      • District of Columbia

      • New York

      • United States Patent and Trademark Office

  • Education
    • J.D., Franklin Pierce Law Center, University of New Hampshire School of Law

    • B.S. Chemistry, Clarkson University with Great Distinction

    X

    Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.